Quantcast

Latest Icaria Stories

2010-07-15 07:30:00

Clinton, N.J., July 15 /PRNewswire/ -- Ikaria, Inc. today announced that Martin Meglasson, Ph.D., will join Ikaria as Chief Science Officer. Dr. Meglasson will be responsible for activities related to early-stage drug development. He will assume his new role at the end of July. "We are delighted to welcome Martin, who will help drive our early-stage assets forward by leveraging his experience and knowledge," commented Douglas Greene, M.D., Executive Vice President of Research and...

2010-06-08 12:00:00

CLINTON, N.J., June 8 /PRNewswire/ -- Ikaria, Inc. today announced that Geoffrey Nichol, M.D., has been appointed Chief Medical Officer. In this newly created role, Dr. Nichol will be responsible for activities related to late-stage drug development. "We are delighted to welcome Geoff, who will leverage his extensive experience in driving our late-stage assets forward," commented Daniel Tasse, Chairman and CEO of Ikaria. "We believe he can help us achieve our vision of becoming a leader...

2010-04-14 07:30:00

CLINTON, N.J., April 14 /PRNewswire/ -- Ikaria Holdings, Inc. today announced that Howard H. Pien has been elected as an independent member of the company's board of directors. Mr. Pien, who has more than 25 years of international management experience in the biopharmaceutical sector, also will become a member of Ikaria's compensation committee. Most recently, he was president, CEO and chairman of Medarex, Inc., which was acquired by Bristol-Myers Squibb in 2009. Mr. Pien currently...

2009-08-10 07:04:00

CLINTON, N.J. and CAMBRIDGE, Mass., Aug. 10 /PRNewswire/ -- Ikaria Holdings, Inc. and Fibrex Medical, Inc. today announced that Ikaria has entered into an agreement under which Ikaria has acquired the exclusive worldwide license to Fibrex Medical's portfolio of investigational compounds for a range of critical care conditions. The investigational compounds, which are known as FX06, FX201, and FX107, are fibrin-derived peptides that bind to vascular endothelial cells, preserving endothelial...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.